Accelerate Diagnostics, Inc. (AXDX)
AXDX Price and Sentiment
AXDX Latest news
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q3 2021 Results - Earnings Call Transcript
2021-11-09 21:52Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q3 2021 Results - Earnings Call Transcript
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates
2021-11-09 20:35Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 57.14% and -11.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Accelerate Diagnostics Reports Third Quarter 2021 Financial Results
2021-11-09 16:05TUCSON, Ariz., Nov. 9, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the third quarter for the period ended September 30, 2021, which remain subject to quarter end closing adjustments.
Earnings Preview: Accelerate Diagnostics (AXDX) Q3 Earnings Expected to Decline
2021-11-02 16:06Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are These 2 Companies Next for Short Squeezes?
2021-10-21 08:07SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.
Accelerate Diagnostics Schedules Call to Review 3rd Quarter 2021 Results
2021-10-19 08:00TUCSON, Ariz., Oct. 19, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, November 9, 2021, at 4:30 p.m.
Accelerate Diagnostics Announces Agreements to Exchange Approximately $51 Million in Principal Amount of Its 2.50% Convertible Senior Notes due 2023 for Common Stock
2021-09-23 09:15TUCSON, Ariz., Sept. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 2.50% Convertible Senior Notes due 2023 (the "Notes").
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript
2021-08-08 10:51Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
2021-08-05 22:03Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -2.86% and -12.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Accelerate Diagnostics Reports Second Quarter 2021 Financial Results
2021-08-05 16:05TUCSON, Ariz., Aug. 5, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2021.